Thema
Journal Article
40
Research Support, Non-U.S. Gov't
29
ixazomib
15
71050168A2
14
Boron Compounds
14
Clinical Trial, Phase I
14
Glycine
13
TE7660XO1C
13
Protein Kinase Inhibitors
12
EC 2.7.10.1
11
HYW8DB273J
11
Randomized Controlled Trial
11
brigatinib
11
Antineoplastic Agents
10
Pharmacokinetics
10
Proteasome Inhibitors
9
Pyrimidines
9
Organophosphorus Compounds
8
Research Support, N.I.H., Extramural
8
Anaplastic Lymphoma Kinase
7
Cytochrome P-450 CYP3A Inhibitors
7
EC 1.14.14.1
7
Ixazomib
7
Review
7
Cytochrome P-450 CYP3A
6
multiple myeloma
6
pharmacokinetics
6
Anaplastic lymphoma kinase
5
Brigatinib
5
ADME
4
AMS
4
Body Surface Area
4
Clinical Trial, Phase II
4
Clinical Trial, Phase III
4
Lenalidomide
4
Mass balance
4
Renal impairment
4
Total radioactivity
4
7S5I7G3JQL
3
Cytochrome P-450 CYP3A Inducers
3
Dexamethasone
3
Multiple myeloma
3
Research Support, U.S. Gov't, Non-P.H.S.
3
Rifampin
3
VJT6J7R4TR
3
304NUG5GF4
2
4340891KFS
2
4Z8R6ORS6L
2
5GRO578KLP
2
Anti-HIV Agents
2
mehr ...